Health
Researchers in Japan compare two seroprevalence antibody tests for SARS-CoV-2 – News-Medical.Net
Researchers have shown that using reliable antibody tests in conjunction is an effective way to estimate seroprevalence in low prevalence settings.
The coronavirus disease 2019 (COVID-19) pandemic, caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), first emerged in Wuhan, China, in December 2019. It has since spread to 192 countries and territories, infecting over 100 million individuals and claiming over 2.2 million lives. To date, Japan has reported 391,945 cases and 5,833 deaths.
A team of researchers in Japan have developed commercially available antibody tests to estimate the seroprevalence of SARS-CoV-2 infection…
-
General23 hours agoMan charged with murder after alleged assault victim dies in Hervey Bay
-
General18 hours agoTaylor Swift breaks Adele’s record for most album sales in first week
-
Noosa News22 hours agoPublic health alert for nitazenes issued after person dies in Queensland
-
Noosa News20 hours agoNoosa Open Studios 2025 Art Trail kicks off today